97 related articles for article (PubMed ID: 26282791)
1. Cancer: leaping the E-cadherin hurdle.
Chen GT; Waterman ML
EMBO J; 2015 Sep; 34(18):2307-9. PubMed ID: 26282791
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin can limit the transforming properties of activating β-catenin mutations.
Huels DJ; Ridgway RA; Radulescu S; Leushacke M; Campbell AD; Biswas S; Leedham S; Serra S; Chetty R; Moreaux G; Parry L; Matthews J; Song F; Hedley A; Kalna G; Ceteci F; Reed KR; Meniel VS; Maguire A; Doyle B; Söderberg O; Barker N; Watson A; Larue L; Clarke AR; Sansom OJ
EMBO J; 2015 Sep; 34(18):2321-33. PubMed ID: 26240067
[TBL] [Abstract][Full Text] [Related]
3. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
4. Intermittent cyclic mechanical tension promotes endplate cartilage degeneration via canonical Wnt signaling pathway and E-cadherin/β-catenin complex cross-talk.
Xu HG; Zheng Q; Song JX; Li J; Wang H; Liu P; Wang J; Wang CD; Zhang XL
Osteoarthritis Cartilage; 2016 Jan; 24(1):158-68. PubMed ID: 26247612
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
6. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
7. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
8. A Regulatory Network Involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling.
Huang TS; Li L; Moalim-Nour L; Jia D; Bai J; Yao Z; Bennett SA; Figeys D; Wang L
Stem Cells; 2015 May; 33(5):1419-33. PubMed ID: 25538040
[TBL] [Abstract][Full Text] [Related]
9. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
Gasior K; Hauck M; Wilson A; Bhattacharya S
Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin-catenin cell-cell adhesion complex and human cancer.
Wijnhoven BP; Dinjens WN; Pignatelli M
Br J Surg; 2000 Aug; 87(8):992-1005. PubMed ID: 10931041
[TBL] [Abstract][Full Text] [Related]
11. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.
Verras M; Sun Z
Cancer Lett; 2006 Jun; 237(1):22-32. PubMed ID: 16023783
[TBL] [Abstract][Full Text] [Related]
12. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.
Conacci-Sorrell M; Simcha I; Ben-Yedidia T; Blechman J; Savagner P; Ben-Ze'ev A
J Cell Biol; 2003 Nov; 163(4):847-57. PubMed ID: 14623871
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the immunohistochemical expression and mutational pattern of the key mediator of Wnt signaling: beta-catenin in Tunisian patients with colorectal carcinoma.
Khiari M; Arfaoui A; Kriaa L; Chaar I; Amara S; Lounis MA; Sammoud S; Dhraeif M; Gharbi L; Mzabi-Regaya S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):62-70. PubMed ID: 21602666
[TBL] [Abstract][Full Text] [Related]
14. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
15. ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.
Bravou V; Klironomos G; Papadaki E; Taraviras S; Varakis J
J Pathol; 2006 Jan; 208(1):91-9. PubMed ID: 16278819
[TBL] [Abstract][Full Text] [Related]
16. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
[TBL] [Abstract][Full Text] [Related]
17. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells.
Dentice M; Luongo C; Ambrosio R; Sibilio A; Casillo A; Iaccarino A; Troncone G; Fenzi G; Larsen PR; Salvatore D
Gastroenterology; 2012 Oct; 143(4):1037-47. PubMed ID: 22771508
[TBL] [Abstract][Full Text] [Related]
19. Exchange of catenins in cadherin-catenin complex.
Klingelhöfer J; Troyanovsky RB; Laur OY; Troyanovsky S
Oncogene; 2003 Feb; 22(8):1181-8. PubMed ID: 12606944
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
Kuphal F; Behrens J
Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
